CLICK to Review Breast Cancer Screening Tour
GET CHECKED NOW: Meet Ms. Christy Johnson, our next Breast Cancer Advocate from the West Coast. She shares with us her crusade for awareness and early detection while discussing the need for supplemental scanning for dense breast tissue. (Click to play video)
The "Are You Dense?" Musicfest is back!
June 25, 2022- Joe Cappello, Executive Director of the ‘Are You Dense?’ Foundation 'brought down the house' at the famous Palace Theater in Waterbury, CT once again. The 2022 Music Fest is about the gift of music, laughter, togetherness and supportive awareness about the awareness of cancer-related breast density health issues. Top honors was presented to Dr. Robert L. Bard, cancer diagnostic imaging expert from NYC. He received the "CHAMPION OF EXPOSING THE SECRET" award for his clinical and research work in doppler ultrasound technology to offer a supplemental solution to dense breast scanning over mammography. Dr. Bard partnered with Mr. Cappello in 2021 to run a 3-day dense breast community scan at the Bard Cancer Imaging Center. They continued their common mission to co-support a pilot study of dense breast screening in underserved communities. (See full article)
News Release: 2022 Research Trial- Dense Breast Detection - 1/11/2022- Dr. Noelle Cutter (Biology professor and clinical researcher from Molloy College) joined with Dr. Robert L. Bard (top NYC radiologist and cancer diagnostic expert) to deploy the 2022 field study to provide breast screening to younger women, subjects with LOW BMI and those in underserved areas. "Through supplemental imaging (ie. 3D Doppler Ultrasound), we can provide better detection of tumors in dense breasts that are concealed by dense breast tissue from mammography." Mammography is the current standard for breast cancer early detection for women 40 & older. Recent studies have shown nearly half of all women who get mammograms are found to have dense breasts, exposing this population to the risk that mammograms may miss potentially cancerous tumors concealed by dense breast tissue. Dr. Cutter's initial concepts to target LOW BMI (bet 12-22% body fat) was personally inspired. As an active TRIATHLETE, her own diagnosis sparked her survey and inquiry throughout the athletic community where she uncovered a significant trend that became the basis for this research. She wishes to target younger women, athletes and members of underserved communities. "Younger women may be more likely to have dense breasts... also I find athletes with LOWER BMI (body mass index) or those with less body fat are more likely to have more dense breast tissue compared with women who are obese." (see full press release)

"R U DENSE?" - (SPECIAL FEATURE FROM THE GREENWICH SENTINEL)
10/21/2021- In the fight against cancer, early detection and prevention are widely promoted through ADVOCACY and PUBLIC EDUCATION. Julia Chiappetta, a recognized survivor-turned-crusader features a major topic about detecting DENSE BREAST tissue and its links to cancer. Since her early educational appointments with the Best Answer for Cancer Foundaton (501c3) to her recent presentations with NYCRA (NY Cancer Resource Alliance), Julia generously shared her wisdom by referencing personal experiences from her diagnosis and the entire journey of her many clinical challenges. Today, she continues to promote the "Get Checked Now!" mantra alongside the "Are You Dense?" Foundation through her remarkable writing style that empowers others, ultimately offering life-saving knowledge to fight, detect or survive cancer. (Click to see GREENWICH SENTINEL article)

click to see program video RESEARCH PROJECT: DENSE BREAST IN ATHLETIC COMMUNITY-
9/22/2021- For women with any level of breast density, one of the major concerns is the alarming rate of false positives that may align with cancers missed by a mammogram. The other concern is that women with dense breasts have a naturally higher risk of breast cancer than women with fatty breasts, and the risk increases with increasing breast density. (This increased risk is separate from the effect of dense breasts on the ability to read a mammogram.). The main focal points of this research project covers the diagnostic study of ATHLETIC WOMEN or those with LOW BODY MASS INDEX (bet 12-22% body fat).

* SPECIAL EVENT *
On July 27-29, we have special limited access to the latest breast scanning technology (CLICK TO SEE 3min VIDEO on the GE Invenia ABUS)

 

On July 27-29, Bard Diagnostic Imaging offered a comprehensive DENSE BREAST SCREENING DAY, employing an array of imaging advancements dedicated to the visibility of dense breast tissue and cancer early detection. This special program was dedicated to supporting dense breasted patients by first identifying one's actual breast density (through a density assessment scan) to establish a base line for the full diagnostic study (est. 15-20 minutes per patient).

For those with any level of breast density, a major concern is the rate of possible cancers that may be missed from to potential misreadings of a mammogram. It is clinically imperative to have a second opinion with the breast sonogram in areas that are more suspicious. A second look of the dense breast area with 3D scanning technology consists of two parts: first is the regular 3D electronic sweep, which gives you a volumetric tissue study. The next is the 4D real-time automated scan, which focuses on the area of concern and the most dense part of the tissue.

Mammogram imaging tends to represent dense tissue as "white" as it also does a small tumor (associate this with a "Polar Bear in a Snowstorm"). Medical interpreters look upon the white tissue as the area where mammograms could miss looming cancers. This is where the 3D and 4D ultrasound imaging comes in; we can now read the density of the tissue which aligns with the potential risk of cancer and navigate through and around the breast giving us the ability to disseminate tissue from tumor. (Read about the data and elevated risk of cancer in dense breasted patients in cancer.org). Through the latest imaging innovation, we have the means to quantify and mitigate this risk by detecting and identifying the "white level" and scanning with the computerized analysis of the volume of suspicious tissue.

SEE COMPLETE DETAILS ON THE BREAST DENSITY DETECTION PILOT PROGRAM
Excerpted from "PinkSmart news"

Ultrasound Significantly Reduces False Readings of DENSE BREASTS
7/8/2021- A wave of recognized medical sites, journals and reports are now indicating that dense breast tissue increases the risk of developing breast cancer and often masks a tumor from being seen on the mammogram since dense tissue is white and cancerous tissue is also white. Mammograms are the standard screening test for breast cancer, however, in the 21st Century, ultrasound non invasive imaging is the preferred exam for dense “lumpy” mammary disease.

(see complete article)

[L- PLAY VIDEO] Dr. Nancy Cappello's Story: "I have dense breast tissue – and women like me (2/3 of pre-menopausal and 1/4 of post menopausal) have less than a 48% chance of having breast cancer detected by a mammogram. In November 2003 I had my yearly mammogram and my "Happy Gram" report that I received stated that my mammogram was "NORMAL" and that there were "no significant findings." Six weeks later at my annual exam... the mammogram revealed "nothing" yet the ultrasound detected a large 2.5 cm suspicious lesion, which was later confirmed to be stage 3c breast cancer, as the cancer had metastasized to 13 lymph nodes..." (click to see complete story)

TAMOXIFEN vs. AROMATASE INHIBITORS FOR MALE BREAST CANCER
In a private conference hosted by the Male Breast Cancer Coalition, our NYCRANEWS editorial team met Dr. Jose Pablo Leone, medical oncologist and researcher at the Dana-Farber Cancer Institute. Discussions covered tamoxifen and aromatase inhibitors for the treatment of male breast cancer, and his research plans in this field.

(see complete article)


SURGICAL EVOLUTION IN BREAST CANCER LOCALIZATION:
WIRE-FREE RADAR IMPLANTS

Wire-free Radar Localization is a pre-surgical procedure to locate and mark the exact breast abnormality through the use of a small, 12×1.6 mm implanted radar reflector device, roughly the size of a grain of rice. This micro-electronic implant communicates with the scanning handpiece, allowing the surgeon to identify the exact tissue (and how much of it) to extract during a lumpectomy [1]. In this feature article, we present Dr. TroyShell-Masouras of Paradise Coast Breast Specialists in Naples Fla. - and David Gilstrap, Director & Global Product Management of Merit Medical. Together, we explored technical perspectives and design strategies behind radar localization and the SCOUT® technology. They shared the procedural advantages provided by the wire-free upgrade as well as its overall improvements to the patient's well-being in the pre and post-surgical phases. (See full article)
 

CLINICAL IMAGING OF BREAST CANCER Explained (click thumbnails for enlarged slide show)
     

These images are an example of practical non-invasive imaging technologies that are currently used worldwide. The Doppler blood flow has been used for 30 years in Europe and Japan. Elastography (also non-invasive modality to show how hard or malignant a tumor is) has been around for 15 years with great success in many countries. A benign looking elastogram scan avoids biopsies in the thyroid, breast, prostate and lymph nodes.

While elastography is relatively new in the United States, the addition of Pet/CT with digital analysis is adding further specificity because chemotherapy, filler and benign tumors can show up as positive findings on a pet CT scan- we have to make sure that what's showing up as a bright lesion is not a false positive. The addition of documenting a hot area on the isotope Pet/CT scan is important to avoid false positives. The latest digital Pet/CT scans are more accurate and quantify true positives and allow you to avoid biopsying false positives. The orchestra of multiple complimentary non-invasive imaging technologies assures a quick and accurate way of determining cancer aggression and accurately allowing you to adjust treatment as needed in a timely matter.


 

Three Staging Options for Advanced Digital Breast Imaging
Advanced sonogram technology provides accurate use of sound waves to produce real-time images of the inside of the body. It is used as a complement to find anomalies and help diagnose the causes of pain, swelling and infection in the body’s internal organs while allowing the diagnostician the ability to zoom and ‘travel’ deep into the body for maximum exploration. Digital Imaging technology is also used to help guide biopsies and in many cases, even replicate much of the same reports of a clinical invasive biopsy. Imaging solutions such as high-powered Sonograms, Spectral Doppler, sonofluoroscopy, 3D/4D Image Reconstruction and the Spectral Doppler are safe, noninvasive, and does not use ionizing radiation. They also have the ability to provide early detection scans. ** Three STAGING OPTIONS are available depending on the patient’s current needs- to be discussed with practitioner prior to or during examination.

Option 1
Option 2
Option 3
BREAST only
Typically performed for patients either self-identifying anomalies (bumps) for the first time and/or are seeking a second opinion + may have a family history of breast cancer (or other related cancers related to the breast)
BREAST & AXILLAE
This option scans the breast and the shoulder through which vessels and nerves enter and leave the upper arm; a person's armpit. This option is recommended for anyone who may be currently Undergoing cancer treatment... also anyone who has recently (prior to 5 years) undergone a mastectomy since it detects unsuspected metastatic disease
BREAST, DUCTS &
LYMPH NODES

For a patient who is at high risk for developing a cancer or requires advanced confirmation of a current tumor treatment protocol since the 3D/4D computer analysis verifies the success of the therapy in a quantitative analysis by the unique Doppler histogram technology

Technology applied:
SONOGRAM

Technology applied:
 SONOGRAM
 SPECTRAL DOPPLER

Technology applied:
 SONOGRAM-HIGH RESOLUTION
 SONOFLUOROSCOPY
 3D/4D IMAGE RECONSTRUCTION
 SPECTRAL DOPPLER


SONOGRAM: Seek subdermal masses, breast lumps, tumor growths, fluid-filled cysts, nodes or hematoma. Sonography can be performed in multiple scan planes with real time 3-D image analysis with power and spectral Doppler flows.
SONOFLUOROSCOPY: of intra/subdermal soft tissues is to be performed in multiple scan planes with varying transducer frequencies.
3D/4D IMAGE RECONSTRUCTION: For any lesions that are homogeneous echogenic and well marginated on 3D and 4D computer histogram analysis.
SPECTRAL DOPPLER: Search for hyperemia of any lesions. Power Doppler will show normal flows in the adjacent arteries/veins. Spectral flows will show normal tri-phasic waveforms. Search for any peripheral lesion abnormalities or focal vascularity.

For more information on Advanced Digital Breast Imaging, contact us at: 212.355.7017



BREAST CANCER SCREENING REGIMEN
The current standard in screening for breast cancer is mammography. However, this imaging tool misses some breast tumors, especially in women with dense breasts. Published data suggests that sonography can play an important role in detecting tumors that mammography misses. In fact, over 94% of cancers seen only on ultrasound were invasive tumors with average size of 10 mm, and in the studies where staging was detailed, 91% were node negative, meaning it had not spread and complete cure was possible due to early detection.

Power Doppler Sonography adds increased accuracy to breast imaging evaluation over ordinary ultrasound because it shows higher blood flow speeds, often a sign of cancerous activity in the breast. Studies have shown that suspicious blood flow identified by pre-surgery Power Doppler scans corresponds very well with the size, location and aggression of actual tumors that are then surgically removed. Thus, Power Doppler brings an important clinical dimension to breast cancer detection. 3D sonography clearly shows tumor margins and 3D Doppler affords an index of cancer aggression and metastatic potential.

 

 

Breast Sonograms and Ultrasound offers the following advantages:
• Highest accuracy in dense (lumpy, cystic) breasts
• Non-invasive-no radiation exposure
• Cost effective
• Can distinguish cysts (fluid-filled masses) from cancerous tumors without needle sampling
• Ease of image guidance for breast biopsy

Women who should consider ultrasound scanning of the breast include those at risk of breast cancer because of personal or family history and the presence of fibrocystic (dense) breast tissue which increases cancer risk by 400%.

(SEE COMPLETE DETAILS)

 

Breast Imaging & Advanced Screening Programs
for New York Women's Groups & Organizations

LET'S UNITE IN THE FIGHT! In the spring of 2018, Bard Cancer Diagnostics (BCD) recently partnered with AWARENESS FOR A CURE and The NY Cancer Resource Alliance to join the battle against breast cancer by establishing a foundation-based Cancer Screening & Monitoring program for all members of non-profit Breast Cancer Organizations and NY-based Women's Groups. This unique program works with all major health providers to bring the most up-to-date technologies and alternative diagnostic solutions (including "2nd Opinion" reviews) and regularly scheduled monitoring and EARLY DETECTION SCANS - all at a significantly reduced rates. BCD also raffles off an Advanced Comprehensive 3/D & 4/D Diagnostic Packages for Breast, Skin and Lung Cancers for qualified organizations- a $2200 value. Inquire about our programs for Women's orgs: email bardcancercenter1@gmail.com
or call 631-920-5757. (vid1)

FAQ about Non-Invasive Sonic Technology & the Future of Cancer Biopsies

Since 1973, Dr. Bard established global recognition in the medical field through his contributions in the advancement of cancer diagnostic innovations. His special use of advanced imaging technologies are widely praised as the painless alternative and a more accurate innovation as well as a much faster solution for acquiring results over surgical biopsies. For the patient, it's a world of difference and immediate peace of mind when the 3D imaging establishes the diagnosis during the examination as you literally see the pictures in front of you in real time.

Q: How accurate is Advanced Sonography in identifying cancers? (open)

Q: Give us an example of your 4D Scan's accuracy over conventional diagnostic methods? (open)

Q: What types of cancers are most commonly captured with this technology? (open)

Q: How can digital scanning be instrumental in Early Detection? (open)

Q: What are the benefits of using the Doppler Ultrasound imaging for BREAST CANCER? (open)

Q: Why scan the lymph nodes in the axillae? (open)

Q: What are the most recent upgrades in the cancer imaging industry? (open)

Q: Can this technology be useful in other health issues and disorders? (open)

MPR-TV reports on Advanced Cancer Doppler Imaging. Meet Dr. Robert L. Bard (award-winning cancer diagnostician and expert imaging specialist) and see him break down the difference between a benign tumor and a fully-blown cancerous cell- and how using his advanced 3D and 4D Doppler technology makes all the time-saving difference in getting an accurate study.

 


SELF-AWARENESS IS JOB 1!

Many routine imaging procedures can assure people that they are at risk for a disease or catastrophic medical event: heart scans, virtual colonoscopies, and lung screening are a few examples of ways to encourage healthy choices (nutrition, supplements, exercise, stress management, etc.) by reinforcing them. BARD CANCER DIAGNOSTICS is founded on the commitment to explore and implement the latest diagnostic technologies as a means of building the proper treatment strategy of many types of cancers. We also specialize in PREVENTION solutions for our patients who strive to maintain a health-conscious lifestyle as well as those who are at increased risk of certain diseases (hereditary factors or environmental exposure to toxic substances) by confirming that their efforts to prevent disease are working.

COMPUTERIZED 3D DOPPLER HISTOGRAM ANALYSIS
Using state-of-the-art equipment, Dr. Bard’s practice offers unique forms of sonography to evaluate blood flow related to tumor activity and to identify areas of suspicion. More tumor vessels signifies more aggressive disease. 3D & 4D analyses are non-invasive and rapid with results available to the patient during the visit. Patients in need of reassurance and world class imaging come from all countries for cancers of the prostate, breast, skin, thyroid and melanoma.

PINK-SMART NEWS IS COMING BACK! In April of 2021, we are publishing new interviews, articles, videos and other educational must-haves for survivors, patients and the community that is breast cancer. With support from some of the top leading foundations, Pink-Smart News will be presented by some of the who's who in Oncology, Immunology, cancer radiology and other areas that support the advancement of cancer care. See archived articles from Pink-Smart News

 


ABOUT OUR PROGRAM

As of Jan '18, Dr. Robert Bard spearheaded a partnership with a host of cancer educators, medical practitioners and non-profit foundations (allied under AwarenessforaCure.org) to form a public resource program to aid in the advancement of the public's understanding about self-preservation from cancer and other chronic diseases. EARLY DETECTION & PREVENTION is a global health movement that promotes a higher regard for "clean living" - from toxins and a toxic lifestyle. Our program consists of four main efforts: EDUCATION, COMMUNITY CONNECTION, CURRENT NEWS & CLINICAL RESOURCES. EARLY DETECTION & PREVENTION brings the empowerment of wellness through group seminars, videos and the distribution of current articles & newsletters published/shared to all the major cancer charities and their members. 

For more information or to subscribe to our EARLY CANCER DETECTION & PREVENTION PROGRAM newsletter, contact Bard Cancer Diagnostics today at: 212.355.7017 - or email us at: bardcancercenter1@gmail.com. Bard Cancer Diagnostics is located at 121 E. 60th St. Suite #6A New York, NY 10022. Visit the complete website: www.CancerScan.com


EARLY DETECTION SAVES LIVES!
According to the World Health Organization, early detection of cancer greatly increases the chances for successful treatment. In the ongoing battle against cancer, it is common knowledge that most cancers in their early stages are far more likely to be treated with positive results. Moreover, a thorough checkup of one's physiological analyses, heredity review and personal data gathering (from blood & dna tests) are all strong info-gatherings for early warning signs that someone may be a candidate for cancer. PROACTIVE tasking starts from AWARENESS, EDUCATION & REGULAR SCREENINGS. The right attitude of self-preservation and an appreciation for longevity is lesson #1. Pursuing a balanced lifestyle covering all the bases of nutrition, exercise, sleep, detoxing and de-stressing is also part of an overall plan for better quality of life.

 

 

 

Copyright © 2018- Bard Diagnostic Publishing. All Rights Reserved.